Potential Novel Therapies for Neurodevelopmental Diseases Targeting Oxidative Stress
Evidence for GLP-1 Use in PCOS Management The evidence base for GLP-1 receptor agonists in PCOS management is evolving, with several clinical trials demonstrating promising metabolic and reproductive benefits, though it remains an off-label indication in the UK
In the RECAP post hoc cohort [42], adults with T2D treated with combined SGLT2i + GLP-1RA (liraglutide or dulaglutide) were evaluated to determine whether treatment sequence or molecule choice influenced renal outcomes
Like any medical weight management approach, Cagrilintide should be prescribed based on an individual assessment, medical history, and personal health goals
This special event brings together our expert team, valued patients, and local partners for a night filled with giving back, exciting prizes, and memorable experiences